Together with the finding that the GM-CSF-induced expression of IRF4 could be inhibited by LXR agonists (32), our data indicate that DEX treatment can trigger a profound immunosuppressive effect in the Scd1+ and Fos+ resident AMs, which further disrupted the anti-infection immunity of the hosts. This evidence concerns the gene IRF4 and infection.